These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2224644)

  • 1. Pathogenicity of Staphylococcus lugdunensis, Staphylococcus schleiferi, and three other coagulase-negative staphylococci in a mouse model and possible virulence factors.
    Lambe DW; Ferguson KP; Keplinger JL; Gemmell CG; Kalbfleisch JH
    Can J Microbiol; 1990 Jul; 36(7):455-63. PubMed ID: 2224644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the pathogenicity of three species of coagulase-negative Staphylococcus in a mouse model with and without a foreign body.
    Ferguson KP; Lambe DW; Keplinger JL; Kalbfleisch JH
    Can J Microbiol; 1991 Sep; 37(9):722-4. PubMed ID: 1954584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host response to coagulase-negative staphylococci in abscesses induced within mice.
    Long JP; Kapral FA
    J Med Microbiol; 1993 Sep; 39(3):191-5. PubMed ID: 8366517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomaterial-associated staphylococcal peritoneal infections in a neutropaenic mouse model.
    Rozalska B; Ljungh A
    FEMS Immunol Med Microbiol; 1995 Jul; 11(4):307-19. PubMed ID: 8541809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of infections due to coagulase-negative staphylococci.
    von Eiff C; Peters G; Heilmann C
    Lancet Infect Dis; 2002 Nov; 2(11):677-85. PubMed ID: 12409048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinically significant coagulase-negative staphylococci: most frequent species and virulence factors].
    Fariña N; Carpinelli L; Samudio M; Guillén R; Laspina F; Sanabria R; Abente S; Rodas L; González P; de Kaspar HM
    Rev Chilena Infectol; 2013 Oct; 30(5):480-8. PubMed ID: 24248161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of coagulase-negative staphylococci, including the newly described species Staphylococcus schleiferi, in nosocomial and community acquired urinary tract infections.
    Oztürkeri H; Kocabeyoğlu O; Yergök YZ; Koşan E; Yenen OS; Keskin K
    Eur J Clin Microbiol Infect Dis; 1994 Dec; 13(12):1076-9. PubMed ID: 7889974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis.
    Frank KL; Del Pozo JL; Patel R
    Clin Microbiol Rev; 2008 Jan; 21(1):111-33. PubMed ID: 18202439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolysins and other characteristics that help differentiate and biotype Staphylococcus lugdunensis and Staphylococcus schleiferi.
    Hébert GA
    J Clin Microbiol; 1990 Nov; 28(11):2425-31. PubMed ID: 2254418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of the glycocalyx of four species of Staphylococcus by transmission electron microscopy and image analysis.
    Lambe DW; Jeffery C; Ferguson KP; Cooper MD
    Microbios; 1994; 78(316):133-43. PubMed ID: 8041290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenicity and virulence of coagulase negative staphylococci in relation to adherence, hydrophobicity, and toxin production in vitro.
    Molnàr C; Hevessy Z; Rozgonyi F; Gemmell CG
    J Clin Pathol; 1994 Aug; 47(8):743-8. PubMed ID: 7962630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virulence of genus Staphylococcus. III. Studies on the pathogenicity to mice.
    Furusawa K; Miyoshi Y
    Bull Tokyo Med Dent Univ; 1975 Mar; 22(1):1-8. PubMed ID: 47790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic features of clinically significant coagulase-negative staphylococci in hospital and community infections in Benin.
    Nanoukon C; Argemi X; Sogbo F; Orekan J; Keller D; Affolabi D; Schramm F; Riegel P; Baba-Moussa L; Prévost G
    Int J Med Microbiol; 2017 Jan; 307(1):75-82. PubMed ID: 27876296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for skin carriage of methicillin-resistant coagulase-positive staphylococci and Staphylococcus schleiferi in dogs with healthy and inflamed skin.
    Griffeth GC; Morris DO; Abraham JL; Shofer FS; Rankin SC
    Vet Dermatol; 2008 Jun; 19(3):142-9. PubMed ID: 18477330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulase-negative staphylococci: pathogenesis, occurrence of antibiotic resistance genes and in vitro effects of antimicrobial agents on biofilm-growing bacteria.
    Szczuka E; Jabłońska L; Kaznowski A
    J Med Microbiol; 2016 Dec; 65(12):1405-1413. PubMed ID: 27902368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative virulence of human isolates of coagulase-negative staphylococci tested in an infant mouse weight retardation model.
    Gunn BA
    J Clin Microbiol; 1989 Mar; 27(3):507-11. PubMed ID: 2715323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Production of staphylokinase and hemolysin by coagulase-negative staphylococcus].
    Sawicka-Grzelak A; Szymanowska A; Młynarczyk A; Młynarczyk G
    Med Dosw Mikrobiol; 1993; 45(1):7-10. PubMed ID: 8231448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coagulase negative staphylococci isolated on blood cultures].
    Simkovicová M; Hanzen J; Milosovic P; Lisalová M
    Epidemiol Mikrobiol Imunol; 2001 Aug; 50(3):117-20. PubMed ID: 11550419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The production of fatty acid modifying enzyme (FAME) and lipase by various staphylococcal species.
    Long JP; Hart J; Albers W; Kapral FA
    J Med Microbiol; 1992 Oct; 37(4):232-4. PubMed ID: 1404319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the virulence of coagulase-negative staphylococci in experimental infections].
    Molnár C; Hevessy Z; Pappné Falusi E; Varga J; Rozgonyiné Szitha K; Rozgonyi F
    Orv Hetil; 1992 Jul; 133(27):1685-8, 1693. PubMed ID: 1625850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.